Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Classement en actions #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Prix de l'action
$0.13607016
Dernière synchronisation: 2024-09-10
Capitalisation boursière
$112.29K
Changement (1 jour)
22.46%
Changement (1 an)
0.00%
Pays
GB
Échange BiVictriX Therapeutics Plc (BVX)

Catégorie

Historique du prix de l'action pour BiVictriX Therapeutics Plc (BVX)
Prix de clôture le plus élevé : $0.11 le 2024-09-01

Prix de clôture le plus bas : $0.30 le 2021-08-01
Historique du prix de l'action de BiVictriX Therapeutics Plc de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 -21.63%
2023 -33.60%
2022 -41.42%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE